BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 27572413)

  • 1. Clinical Characteristics, Treatment Outcomes, and Resistance Mutations Associated with Macrolide-Resistant Mycobacterium avium Complex Lung Disease.
    Moon SM; Park HY; Kim SY; Jhun BW; Lee H; Jeon K; Kim DH; Huh HJ; Ki CS; Lee NY; Kim HK; Choi YS; Kim J; Lee SH; Kim CK; Shin SJ; Daley CL; Koh WJ
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6758-6765. PubMed ID: 27572413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and molecular analysis of macrolide resistance in Mycobacterium avium complex lung disease.
    Griffith DE; Brown-Elliott BA; Langsjoen B; Zhang Y; Pan X; Girard W; Nelson K; Caccitolo J; Alvarez J; Shepherd S; Wilson R; Graviss EA; Wallace RJ
    Am J Respir Crit Care Med; 2006 Oct; 174(8):928-34. PubMed ID: 16858014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of Macrolide Resistance and Reinfection in Refractory Mycobacterium avium Complex Lung Disease.
    Jhun BW; Kim SY; Moon SM; Jeon K; Kwon OJ; Huh HJ; Ki CS; Lee NY; Shin SJ; Daley CL; Koh WJ
    Am J Respir Crit Care Med; 2018 Nov; 198(10):1322-1330. PubMed ID: 29877739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Characteristics and Treatment Outcomes of Patients with Macrolide-Resistant Mycobacterium massiliense Lung Disease.
    Choi H; Kim SY; Lee H; Jhun BW; Park HY; Jeon K; Kim DH; Huh HJ; Ki CS; Lee NY; Lee SH; Shin SJ; Daley CL; Koh WJ
    Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27872066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Rapid Screening Assay for Clarithromycin-Resistant Mycobacterium avium Complex Using Melting Curve Analysis with Nonfluorescent Labeled Probes.
    Aoki A; Jinno H; Ogawa K; Nakagawa T; Inagaki T; Wajima T; Okamoto Y; Uchiya KI
    Microbiol Spectr; 2023 Feb; 11(1):e0432622. PubMed ID: 36622171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics and treatment outcomes of patients with macrolide-resistant Mycobacterium avium complex pulmonary disease: a systematic review and meta-analysis.
    Park Y; Lee EH; Jung I; Park G; Kang YA
    Respir Res; 2019 Dec; 20(1):286. PubMed ID: 31852452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intermittent antibiotic therapy for nodular bronchiectatic Mycobacterium avium complex lung disease.
    Jeong BH; Jeon K; Park HY; Kim SY; Lee KS; Huh HJ; Ki CS; Lee NY; Shin SJ; Daley CL; Koh WJ
    Am J Respir Crit Care Med; 2015 Jan; 191(1):96-103. PubMed ID: 25393520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Characteristics and Treatment Outcomes of Patients with Acquired Macrolide-Resistant Mycobacterium abscessus Lung Disease.
    Choi H; Kim SY; Kim DH; Huh HJ; Ki CS; Lee NY; Lee SH; Shin S; Shin SJ; Daley CL; Koh WJ
    Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28739795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peak Plasma Concentration of Azithromycin and Treatment Responses in Mycobacterium avium Complex Lung Disease.
    Jeong BH; Jeon K; Park HY; Moon SM; Kim SY; Lee SY; Shin SJ; Daley CL; Koh WJ
    Antimicrob Agents Chemother; 2016 Oct; 60(10):6076-83. PubMed ID: 27480854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term Follow-up of Mycobacterium avium Complex Lung Disease in Patients Treated With Regimens Including Clofazimine and/or Rifampin.
    Jarand J; Davis JP; Cowie RL; Field SK; Fisher DA
    Chest; 2016 May; 149(5):1285-93. PubMed ID: 26513209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrolide resistant Mycobacterium avium complex pulmonary disease following clarithromycin and ethambutol combination therapy.
    Ito Y; Miwa S; Shirai M; Kanai M; Fujita K; Ohba H; Iwaizumi E; Oshima T; Kojima S; Suda T; Hayakawa H
    Respir Med; 2020 Aug; 169():106025. PubMed ID: 32442113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of drug treatment outcome in clarithromycin-resistant Mycobacterium avium complex lung disease.
    Kadota T; Matsui H; Hirose T; Suzuki J; Saito M; Akaba T; Kobayashi K; Akashi S; Kawashima M; Tamura A; Nagai H; Akagawa S; Kobayashi N; Ohta K
    BMC Infect Dis; 2016 Jan; 16():31. PubMed ID: 26818764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrolide/Azalide therapy for nodular/bronchiectatic mycobacterium avium complex lung disease.
    Wallace RJ; Brown-Elliott BA; McNulty S; Philley JV; Killingley J; Wilson RW; York DS; Shepherd S; Griffith DE
    Chest; 2014 Aug; 146(2):276-282. PubMed ID: 24457542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical features of patients with bacteraemia caused by Mycobacterium avium complex species and antimicrobial susceptibility of the isolates at a medical centre in Taiwan, 2008-2014.
    Lee MR; Chien JY; Huang YT; Liao CH; Shu CC; Yu CJ; Hsueh PR
    Int J Antimicrob Agents; 2017 Jul; 50(1):35-40. PubMed ID: 28478210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of ethambutol on emergence of clarithromycin-resistant Mycobacterium avium complex in the beige mouse model.
    Bermudez LE; Nash KA; Petrofsky M; Young LS; Inderlied CB
    J Infect Dis; 1996 Dec; 174(6):1218-22. PubMed ID: 8940212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of ethambutol and rifampicin in the treatment of Mycobacterium avium complex pulmonary disease.
    Kim HJ; Lee JS; Kwak N; Cho J; Lee CH; Han SK; Yim JJ
    BMC Pulm Med; 2019 Nov; 19(1):212. PubMed ID: 31711459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective treatment for clarithromycin-resistant Mycobacterium avium complex lung disease.
    Adachi Y; Tsuyuguchi K; Kobayashi T; Kurahara Y; Yoshida S; Kagawa T; Hayashi S; Suzuki K
    J Infect Chemother; 2020 Jul; 26(7):676-680. PubMed ID: 32171660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of refractory Mycobacterium avium complex lung disease with a moxifloxacin-containing regimen.
    Koh WJ; Hong G; Kim SY; Jeong BH; Park HY; Jeon K; Kwon OJ; Lee SH; Kim CK; Shin SJ
    Antimicrob Agents Chemother; 2013 May; 57(5):2281-5. PubMed ID: 23478956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycobacterium avium complex pulmonary disease: management options in HIV-negative patients.
    Ramirez J; Mason C; Ali J; Lopez FA
    J La State Med Soc; 2008; 160(5):248-54; quiz 254, 293. PubMed ID: 19048978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PCR-Based Rapid Identification System Using Bridged Nucleic Acids for Detection of Clarithromycin-Resistant Mycobacterium avium-M. intracellulare Complex Isolates.
    Hirama T; Shiono A; Egashira H; Kishi E; Hagiwara K; Nakamura H; Kanazawa M; Nagata M
    J Clin Microbiol; 2016 Mar; 54(3):699-704. PubMed ID: 26739154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.